Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4197 stock hub

TPEX/4197 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4197is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

336.5M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4197

In the news

Latest news · TPEX/4197

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E65.6

P25 14.4P50 18P75 31.9

ROE2.7

P25 -16.2P50 0.3P75 9.8

ROIC1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4197 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

200

Groups with data

Currency

TWD

Showing 200 of 200 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	98
Employees Change	16%
Employees Change Percent	19.51
Enterprise value	TWD 362.5M
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	TW0004197009
Last refreshed	2026-05-10
Market cap	TWD 336.5M
Price	TWD 10.8
Price currency	TWD
Rev Per Employee	1,827,122.45x
Sector	Healthcare
Sic	3845
Symbol	tpex/4197
Website	https://www.visgeneer.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.56%
EV Earnings	69.1x
EV/EBIT	54.02x
EV/EBITDA	18.78x
EV/FCF	39.43x
EV/Sales	2.02x
FCF yield	2.73%
P/B ratio	1.69x
P/E ratio	65.59x
P/S ratio	1.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.75%
EBITDA Margin	10.78%
FCF margin	5.14%
Gross margin	38.2%
Gross Profit	TWD 68.4M
Gross Profit Growth	42.73%
Gross Profit Growth Q	107.49%
Gross Profit Growth3 Y	4.05%
Gross Profit Growth5 Y	2.46%
Net Income	TWD 5.2M
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Pretax Margin	2.93%
Profit Margin	2.93%
Profit Per Employee	TWD 53,541
Profitable Years	1
ROA	1.26
Roa5y	-1.16
ROCE	2.28
ROE	2.67
Roe5y	-2.29
ROIC	1.01
Roic5y	-3.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.13%
Cagr1y	2.86%
Cagr3y	-3.85%
Cagr5y	-4.37%
Div CAGR10	0%
EPS Growth Quarters	3
EPS Growth Years	2
FCF Growth3 Y	20.35%
FCF Growth5 Y	-12.32%
OCF Growth3 Y	22.48%
OCF Growth5 Y	-11.06%
Revenue Growth	33.94x
Revenue Growth Q	95.74x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	2.58x
Revenue Growth5 Y	0.23x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.54
Assets	TWD 335M
Cash	TWD 69.3M
Current Assets	TWD 156.8M
Current Liabilities	TWD 47.5M
Debt	TWD 95.4M
Debt EBITDA	TWD 4.94
Debt Equity	TWD 0.48
Debt FCF	TWD 10.37
Equity	TWD 199.1M
Interest Coverage	2.77
Liabilities	TWD 135.9M
Long Term Assets	TWD 178.2M
Long Term Liabilities	TWD 88.5M
Net Cash	TWD -26M
Net Cash By Market Cap	TWD -7.74
Net Debt EBITDA	TWD 1.35
Net Debt Equity	TWD 0.13
Net Debt FCF	TWD 2.83
Tangible Book Value	TWD 198.9M
Tangible Book Value Per Share	TWD 6.3
WACC	4.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.69
Inventory Turnover	2.21
Net Working Capital	TWD 39.6M
Quick ratio	2.29
Working Capital	TWD 108.9M
Working Capital Turnover	TWD 1.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	TWD 0
Last Dividend	TWD 0.25

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-46.87%
1Y total return	2.86%
200-day SMA	10.44
3Y total return	-11.11%
50-day SMA	10.65
50-day SMA vs 200-day SMA	50over200
5Y total return	-20%
All Time High	49.62
All Time High Change	-78.23%
All Time High Date	2013-12-05
All Time Low	8.15
All Time Low Change	32.52%
All Time Low Date	2026-04-13
ATR	1.54
Beta	0.28
Beta1y	0.9
Beta2y	0.53
Ch YTD	11.34
High	11.15
High52	22.5
High52 Date	2026-04-21
High52ch	-52%
Low	10.65
Low52	8.15
Low52 Date	2026-04-13
Low52ch	32.52%
Ma50ch	1.41%
Price vs 200-day SMA	3.45%
RSI	47.16
RSI Monthly	53.07
RSI Weekly	53.03
Sharpe ratio	0.23x
Sortino ratio	0.53
Tr YTD	11.34
Tr1m	20%
Tr1w	-10%
Tr3m	9.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 6.7M
Operating Income Growth5 Y	-8.78
Operating margin	3.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,143,394%
Net Borrowing	-44,434,000
Shares Insiders	20.01%
Shares Out	30,180,925
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 9.2M
Average Volume	481,691.05x
Bv Per Share	6.31
CAPEX	TWD -4.2M
Ch10y	-47.48
Ch1m	20
Ch1w	-10
Ch1y	2.86
Ch3m	9.65
Ch3y	-11.11
Ch5y	-20
Ch6m	4.85
Change	-1.82%
Change From Open	0.47
Close	11
Days Gap	-2.27
Depreciation Amortization	13,389,000
Dollar Volume	1,037,955.6
Earnings Date	2026-05-14
EBIT	TWD 6.7M
EBITDA	TWD 19.3M
EPS	TWD 0.17
F Score	6
FCF	TWD 9.2M
FCF EV Yield	2.54x
FCF Per Share	TWD 0.3
Financing CF	-9,634,000
Fiscal Year End	December
Founded	2,005
Graham Number	4.91304
Graham Upside	-54.51
Investing CF	-4,815,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-06-30
Last Split Date	2016-07-12
Last Split Type	Forward
Ma150	10.45
Ma150ch	3.33%
Ma20	12.46
Ma20ch	-13.29%
Net CF	-1,083,000
Next Earnings Date	2026-05-14
Open	10.75
P FCF Ratio	36.6
P OCF Ratio	25.18
Position In Range	30
Ppne	180,101,000
Price Date	2026-05-08
Price EBITDA	TWD 17.43
Ptbv Ratio	1.69
Relative Volume	0.2x
Revenue	179,058,000x
Tr6m	4.85%
Volume	96,107

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/4197 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4197 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4197?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+20.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TPEX/4197 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.2

Neutral momentum band

Price vs 200-day MA

+3.4%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4197

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4197 stock rating?

tpex/4197 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4197 analysis?

The full report lives at /stocks/tpex/4197/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4197?

The latest report frames tpex/4197 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4197 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.